JPMorgan Chase Financial Co. LLC has filed a pricing supplement for $295,000 in structured investments linked to the MerQube US Large-Cap Vol Advantage Index. This filing, dated October 29, 2026, is significant as it reflects the company's strategy to enhance its product offerings in the competitive national commercial banking sector.
Background
JPMorgan Chase Financial Co. LLC, a wholly owned subsidiary of JPMorgan Chase & Co., is incorporated in Delaware and classified under the Standard Industrial Classification (SIC) number 6021, which represents national commercial banks. The company operates from its headquarters at 383 Madison Avenue, New York, NY.
What the Filing Says
The filing details the issuance of Review Notes linked to the MerQube US Large-Cap Vol Advantage Index, which are due on October 30, 2031. The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. Investors are informed that the notes are designed for those seeking early exit prior to maturity at a premium if the index level meets specific criteria. The filing states, "The notes priced on October 27, 2026, and are expected to settle on or about October 30, 2026." Additionally, it mentions that the notes are unsecured obligations of JPMorgan Chase Financial, subject to the credit risk of both the issuer and the guarantor.
Impact
This filing may affect investors looking for structured investment products, particularly those interested in the performance of the MerQube US Large-Cap Vol Advantage Index. The structure of these notes, which includes a 6.0% per annum daily deduction, indicates a potential for both risk and reward, appealing to a segment of investors willing to navigate these complexities.
What's Next
The filing does not say what happens next.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity









